This study includes two parts.A clinical trial with a open-label to evaluate the safety of Sabin Inactivated Poliovirus Vaccine (Vero cell) (2.5ml-5 doses)(hereinafter referred to as "msIPV")manufactured by Sinovac Biotech Co., Ltd. in adults, children and infants in partâ… and a blinded,randomized and controlled clinical trial to evaluate the lot consistency immunogenicity, and safety of the msIPV in 2 months old infants in partâ…¡.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety index-incidence of adverse reactions
Timeframe: Within 30 days after each dose
Immunogenicity index-Geometric mean titers (GMT)
Timeframe: 30 days after primary immunization
Immunogenicity index- seroconversion rate of neutralizing antibody
Timeframe: 30 days after primary immunization